Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / CL A
-
Number of holders
-
93
-
Total 13F shares, excl. options
-
12,214,064
-
Shares change
-
+749,924
-
Total reported value, excl. options
-
$427,112,324
-
Value change
-
+$36,655,592
-
Put/Call ratio
-
53%
-
Number of buys
-
60
-
Number of sells
-
-28
-
Price
-
$34.97
Significant Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q2 2018
109 filings reported holding RETA - REATA PHARMACEUTICALS INC - CL A as of Q2 2018.
REATA PHARMACEUTICALS INC - CL A (RETA) has 93 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,214,064 shares
.
Largest 10 shareholders include CPMG Inc (2,912,523 shares), BlackRock Inc. (1,503,780 shares), VANGUARD GROUP INC (678,306 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (609,554 shares), EMERALD ADVISERS INC/PA (545,520 shares), EMERALD MUTUAL FUND ADVISERS TRUST (486,741 shares), FMR LLC (468,990 shares), Cormorant Asset Management, LP (450,000 shares), AMERIPRISE FINANCIAL INC (406,723 shares), and BOXER CAPITAL, LLC (325,000 shares).
This table shows the top 93 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.